Brazil launches hepatitis programme
This article was originally published in Clinica
Executive Summary
Brazil has launched a national hepatitis control programme, to improve the detection, prevention, epidemiological surveillance and treatment of the A, B and C strains of the disease. The programme is backed by legislation enforcing the use of nucleic acid testing (NAT) to screen all donated blood for hepatitis C and HIV/AIDS, with the aim of reducing the high incidence of these diseases in Brazil.